FAQ/Help |
Calendar |
Search |
Today's Posts |
05-01-2020, 01:40 PM | #1 | |||
|
||||
Senior Member
|
I hate to post this news because some people here may be taking Ocrevus or hoping to take it soon. PML is a rarely occurring "adverse event" for some of the MS drugs, and now it seems that Ocrevus is among them. Earlier cases of PML in patients on Ocrevus were thought to have occurred because those patients had been on other MS drugs before Ocrevus. This new case, which ended in death, was in a patient for whom Ocrevus was the first MS drug.
Quote:
Report Details First Case of PML With Ocrelizumab Alone The abstract of the report mentioned in the Medscape article: 2020 American Academy of Neurology Abstract Website
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis, osteopenia. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, 12/16/20 - 3/16/24 |
|||
Reply With Quote |
Reply |
Thread Tools | |
Display Modes | |
|
|
Similar Threads | ||||
Thread | Forum | |||
Subsidised Ocrelizumab/Ocrevus in Australia | Parkinson's Disease | |||
Ocrelizumab | Multiple Sclerosis | |||
remember me? And - Ocrelizumab study? | Multiple Sclerosis | |||
Ocrelizumab drug trial? | Arthritis | |||
Ocrelizumab? | Autoimmune Diseases |